BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Muro M, López-Hernández R, Mrowiec A. Immunogenetic biomarkers in inflammatory bowel diseases: Role of the IBD3 region. World J Gastroenterol 2014; 20(41): 15037-15048 [PMID: 25386052 DOI: 10.3748/wjg.v20.i41.15037]
URL: https://www.wjgnet.com/1007-9327/full/v20/i41/15037.htm
Number Citing Articles
1
Leiyan Wei, Zhiqing Xiang, Yizhou Zou. The Role of NKG2D and Its Ligands in Autoimmune Diseases: New Targets for ImmunotherapyInternational Journal of Molecular Sciences 2023; 24(24): 17545 doi: 10.3390/ijms242417545
2
Sarah S. Abdul-Hussein, Ekhlass N. Ali, Neihaya H. Zaki, Ali H. Ad’hiah. Genetic polymorphism of HLA-G gene (G*01:03, G*01:04, and G*01:05N) in Iraqi patients with inflammatory bowel disease (ulcerative colitis and Crohn’s disease)Egyptian Journal of Medical Human Genetics 2021; 22(1) doi: 10.1186/s43042-021-00158-9
3
Alessandro Poggi, Roberto Benelli, Roberta Venè, Delfina Costa, Nicoletta Ferrari, Francesca Tosetti, Maria Raffaella Zocchi. Human Gut-Associated Natural Killer Cells in Health and DiseaseFrontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.00961
4
M. Tavares, C. de Lima, W. Fernandes, V. Martinelli, M. de Lucena, F. Lima, A. Telles, L. Brandão, M. de Melo Júnior. Tumour necrosis factor‐alpha (‐308G/A) promoter polymorphism is associated with ulcerative colitis in Brazilian patientsInternational Journal of Immunogenetics 2016; 43(6): 376 doi: 10.1111/iji.12289
5
Rita Lauro, Federica Mannino, Natasha Irrera, Francesco Squadrito, Domenica Altavilla, Giovanni Squadrito, Giovanni Pallio, Alessandra Bitto. Pharmacogenetics of Biological Agents Used in Inflammatory Bowel Disease: A Systematic ReviewBiomedicines 2021; 9(12): 1748 doi: 10.3390/biomedicines9121748
6
Manuel Muro, Anna Mrowiec. Interleukin (IL)-1 Gene Cluster in Inflammatory Bowel Disease: Is IL-1RA Implicated in the Disease Onset and Outcome?Digestive Diseases and Sciences 2015; 60(5): 1126 doi: 10.1007/s10620-015-3571-6
7
Ruth López‐Hernández, Jose A. Campillo, Isabel Legaz, Mariano Valdés, Hortensia Salama, Francisco Boix, AM Hernández‐Martínez, Jorge Eguia, G González‐Martínez, Maria R. Moya‐Quiles, Alfredo Minguela, Ana García‐Alonso, Fernando Carballo, Manuel Muro. Killer immunoglobulin‐like receptor repertoire analysis in a Caucasian Spanish cohort with inflammatory bowel diseaseMicrobiology and Immunology 2016; 60(11): 787 doi: 10.1111/1348-0421.12447
8
T M Linares-Pineda, M Cañadas-Garre, A Sánchez-Pozo, M Á Calleja-Hernández. Pharmacogenetic biomarkers of response in Crohn’s diseaseThe Pharmacogenomics Journal 2018; 18(1): 1 doi: 10.1038/tpj.2017.27
9
Iolanda Agliata, Nora Fernandez-Jimenez, Chloe Goldsmith, Julien C. Marie, Jose R. Bilbao, Robert Dante, Hector Hernandez-Vargas. The DNA methylome of inflammatory bowel disease (IBD) reflects intrinsic and extrinsic factors in intestinal mucosal cellsEpigenetics 2020; 15(10): 1068 doi: 10.1080/15592294.2020.1748916
10
Chang Cun Guo, Ni Wei, Shu Hui Liang, Biao Luo Wang, Su Mei Sha, Kai Chun Wu. Population‐specific genome‐wide mapping of expression quantitative trait loci in the colon of Han ChineseJournal of Digestive Diseases 2016; 17(9): 600 doi: 10.1111/1751-2980.12399
11
Francesco Giudici, Letizia Lombardelli, Edda Russo, Tiziana Cavalli, Daniela Zambonin, Federica Logiodice, Ornela Kullolli, Lamberto Giusti, Tatiana Bargellini, Marilena Fazi, Livia Biancone, Stefano Scaringi, Ann Maria Clemente, Eloisa Perissi, Giovanni Delfino, Maria G Torcia, Ferdinando Ficari, Francesco Tonelli, Marie-Pierre Piccinni, Cecilia Malentacchi. Multiplex gene expression profile in inflamed mucosa of patients with Crohn’s disease ileal localization: A pilot studyWorld Journal of Clinical Cases 2019; 7(17): 2463-2476 doi: 10.12998/wjcc.v7.i17.2463